NCT00002260View on ClinicalTrials.gov

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Alovudine

Trial Locations (1)

21205

Johns Hopkins Hosp, Baltimore

Sponsors
All Listed Sponsors
lead

Lederle Laboratories

INDUSTRY

NCT00002260 - An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects | Biotech Hunter | Biotech Hunter